Home/Filings/4/0001437749-22-013570
4//SEC Filing

Mickle Travis C 4

Accession 0001437749-22-013570

CIK 0001434647other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 9:03 PM ET

Size

9.7 KB

Accession

0001437749-22-013570

Insider Transaction Report

Form 4
Period: 2022-05-25
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2022-05-25$4.39/sh+10,000$43,90011,034 total(indirect: By LLC)
  • Purchase

    Common Stock

    2022-05-25$4.36/sh+2,000$8,71138,521 total
  • Purchase

    Common Stock

    2022-05-25$4.38/sh+1,000$4,38539,521 total
Holdings
  • Common Stock

    (indirect: By Trust)
    15,242
  • Common Stock

    (indirect: By Trust)
    9,824
  • Common Stock

    (indirect: By LLC)
    96,153
Footnotes (2)
  • [F1]The Reporting Person is the sole manager member of Mickle Investments, LLC.
  • [F2]The Reporting Person is the sole manager member of Mickle Holdings, LLC.

Issuer

KEMPHARM, INC

CIK 0001434647

Entity typeother

Related Parties

1
  • filerCIK 0001638365

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 9:03 PM ET
Size
9.7 KB